Page last updated: 2024-10-31

metyrapone and HIV Coinfection

metyrapone has been researched along with HIV Coinfection in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koutkia, P1
Berry, J1
Eaton, K1
Breu, J1
Grinspoon, S1
Eledrisi, MS1
Verghese, AC1

Reviews

1 review available for metyrapone and HIV Coinfection

ArticleYear
Adrenal insufficiency in HIV infection: a review and recommendations.
    The American journal of the medical sciences, 2001, Volume: 321, Issue:2

    Topics: Adrenal Glands; Adrenal Insufficiency; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents

2001

Trials

1 trial available for metyrapone and HIV Coinfection

ArticleYear
Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women.
    American journal of physiology. Endocrinology and metabolism, 2006, Volume: 290, Issue:5

    Topics: Adolescent; Adrenal Glands; Adult; Androgens; Androstenedione; Cortodoxone; Cosyntropin; Dehydroepia

2006